Literature DB >> 23151603

Future directions in cancer prevention.

Asad Umar1, Barbara K Dunn, Peter Greenwald.   

Abstract

Prevention of cancer remains the most promising strategy for reducing both its incidence and the mortality due to this disease. For more than four decades, findings from epidemiology, basic research and clinical trials have informed the development of lifestyle and medical approaches to cancer prevention. These include selective oestrogen receptor modulators and aromatase inhibitors for breast cancer, the 5-α-reductase inhibitors finasteride and dutasteride for prostate cancer, and the development of vaccines for viruses that are associated with specific cancers. Future directions include genetic, proteomic and other molecular approaches for identifying pathways that are associated with cancer initiation and development, as well as refining the search for immunologically modifiable causes of cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23151603     DOI: 10.1038/nrc3397

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  159 in total

Review 1.  The diversity of T-cell co-stimulation in the induction of antitumor immunity.

Authors:  J Schlom; J W Hodge
Journal:  Immunol Rev       Date:  1999-08       Impact factor: 12.988

2.  The lack, need, and opportunities for decision-making and informational tools to educate primary-care physicians and women about breast cancer chemoprevention.

Authors:  Peter M Ravdin
Journal:  Cancer Prev Res (Phila)       Date:  2010-06

3.  Public health. Brawling over mammography.

Authors:  Eliot Marshall
Journal:  Science       Date:  2010-02-19       Impact factor: 47.728

4.  Development of a DNA vaccine targeting Merkel cell polyomavirus.

Authors:  Qi Zeng; Bianca P Gomez; Raphael P Viscidi; Shiwen Peng; Liangmei He; Barbara Ma; T-C Wu; Chien-Fu Hung
Journal:  Vaccine       Date:  2011-12-29       Impact factor: 3.641

Review 5.  Cancer treatment and survivorship statistics, 2012.

Authors:  Rebecca Siegel; Carol DeSantis; Katherine Virgo; Kevin Stein; Angela Mariotto; Tenbroeck Smith; Dexter Cooper; Ted Gansler; Catherine Lerro; Stacey Fedewa; Chunchieh Lin; Corinne Leach; Rachel Spillers Cannady; Hyunsoon Cho; Steve Scoppa; Mark Hachey; Rebecca Kirch; Ahmedin Jemal; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2012-06-14       Impact factor: 508.702

6.  Changing human behavior to prevent disease: the importance of targeting automatic processes.

Authors:  Theresa M Marteau; Gareth J Hollands; Paul C Fletcher
Journal:  Science       Date:  2012-09-21       Impact factor: 47.728

7.  AFP-specific immunotherapy impairs growth of autochthonous hepatocellular carcinoma in mice.

Authors:  Jeannette Cany; Benoît Barteau; Lucile Tran; Vanessa Gauttier; Isabelle Archambeaud; Jean-Pierre Couty; Bruno Turlin; Bruno Pitard; Georges Vassaux; Nicolas Ferry; Sophie Conchon
Journal:  J Hepatol       Date:  2010-08-26       Impact factor: 25.083

8.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

Review 9.  Cowden syndrome: a critical review of the clinical literature.

Authors:  Robert Pilarski
Journal:  J Genet Couns       Date:  2008-10-30       Impact factor: 2.537

10.  Immunomodulation by imiquimod in patients with high-risk primary melanoma.

Authors:  Rupa Narayan; Hong Nguyen; Jason J Bentow; Lauren Moy; Diana K Lee; Stephanie Greger; Jacquelyn Haskell; Veena Vanchinathan; Pei-Lin Chang; Shanli Tsui; Tamiko Konishi; Begonya Comin-Anduix; Christine Dauphine; Hernan I Vargas; James S Economou; Antoni Ribas; Kevin W Bruhn; Noah Craft
Journal:  J Invest Dermatol       Date:  2011-08-18       Impact factor: 8.551

View more
  79 in total

1.  NLRP1 and NTN1, Deregulated Blood Differentially Methylated Regions in Mild Cognitive Impairment Patients.

Authors:  Min-Koo Park; Ji-Won Lee; Jeong-Chan Lee; Sung-Joo Hwang; Hyun Woong Roh; Chang Hyung Hong; Sang Joon Son
Journal:  J Mol Neurosci       Date:  2018-11-05       Impact factor: 3.444

Review 2.  Food-based natural products for cancer management: Is the whole greater than the sum of the parts?

Authors:  Suleman S Hussain; Addanki P Kumar; Rita Ghosh
Journal:  Semin Cancer Biol       Date:  2016-07-07       Impact factor: 15.707

Review 3.  Emerging applications of metabolomics in studying chemopreventive phytochemicals.

Authors:  Lei Wang; Chi Chen
Journal:  AAPS J       Date:  2013-06-22       Impact factor: 4.009

4.  Disease Subtype-Independent Biomarkers of Breast Cancer Chemoprevention by the Ayurvedic Medicine Phytochemical Withaferin A.

Authors:  Suman K Samanta; Anuradha Sehrawat; Su-Hyeong Kim; Eun-Ryeong Hahm; Yongli Shuai; Ruchi Roy; Subrata K Pore; Krishna B Singh; Susan M Christner; Jan H Beumer; Nancy E Davidson; Shivendra V Singh
Journal:  J Natl Cancer Inst       Date:  2016-12-31       Impact factor: 13.506

5.  Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States.

Authors:  Hannah P Yang; William F Anderson; Philip S Rosenberg; Britton Trabert; Gretchen L Gierach; Nicolas Wentzensen; Kathleen A Cronin; Mark E Sherman
Journal:  J Clin Oncol       Date:  2013-05-06       Impact factor: 44.544

Review 6.  Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.

Authors:  Guido Eibl; Zobeida Cruz-Monserrate; Murray Korc; Maxim S Petrov; Mark O Goodarzi; William E Fisher; Aida Habtezion; Aurelia Lugea; Stephen J Pandol; Phil A Hart; Dana K Andersen
Journal:  J Acad Nutr Diet       Date:  2017-09-12       Impact factor: 4.910

7.  Future directions for postdoctoral training in cancer prevention: insights from a panel of experts.

Authors:  David E Nelson; Jessica Faupel-Badger; Siobhan Phillips; Britni Belcher; Shine Chang; David B Abrams; Barnett S Kramer; Mary C White; Michael O'Malley; Arti P Varanasi; Carol J Fabian; Jonathan S Wiest; Graham A Colditz; Kara Hall; Peter G Shields; Jeffrey N Weitzel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03-06       Impact factor: 4.254

8.  Health Promoting Life-Style Behaviors and Systemic Inflamma-tion in African American and Caucasian Women Prior to Chemo-therapy for Breast Cancer.

Authors:  Debra E Lyon; Lathika Mohanraj; Debra Lynch Kelly; Rk Elswick
Journal:  Health Promot Perspect       Date:  2014-07-12

Review 9.  Fanconi anaemia and cancer: an intricate relationship.

Authors:  Grzegorz Nalepa; D Wade Clapp
Journal:  Nat Rev Cancer       Date:  2018-01-29       Impact factor: 60.716

Review 10.  The National Cancer Institute's PREVENT Cancer Preclinical Drug Development Program: overview, current projects, animal models, agent development strategies, and molecular targets.

Authors:  Robert H Shoemaker; Chen S Suen; Cathy A Holmes; Judith R Fay; Vernon E Steele
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.